Skip to main content
Clinical Trials/NCT00906958
NCT00906958CompletedNot Applicable

Comparison of the Efficacy and Subjective Comfort of a Modified AutoSet Device With an Existing AutoSet Device (VPAP Auto) in Treating Obstructive Sleep Apnea

ResMed1 site in 1 country20 target enrollmentStarted: May 11, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Oxygen Desaturation Index

Study Overview

Brief Summary

The purpose of this study is to determine if the performance of the modified AutoSet device is equivalent or better than the existing AutoSet device (VPAP Auto) in the efficacy of the treatment and the subjective comfort.

Detailed Description

Obstructive sleep apnea (OSA) is characterised by a partial or complete collapse of the upper airway during sleep. The treatment of choice for OSA is Continuous Positive Airway Pressure (CPAP). CPAP acts as a positive airway splint, delivering a fixed or auto adjusted positive pressure to the upper airway via a tube and mask. The modified device to be assessed in this study will act in a similar way to the existing device, VPAP Auto, but utilizes an improved algorithm which should maintain or enhance the effectiveness of the treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients aged 18-80 years
  • •Patients who are on CPAP therapy in AUTOSET mode for no less than 6 months
  • •Patients who are using ResMed masks

Exclusion Criteria

  • •Patients who are unable to provide written informed consent
  • •Patients who are unable to comprehend written and spoken English
  • •Patients who are using Bilevel PAP
  • •Patients who are pregnant
  • •Patients who are suffering any of the following:
  • •Acute respiratory infection
  • •Acute sinusitis, otitis media or perforated eardrum
  • •Pneumothorax or pneumomediastinum
  • •Recent history of severe epistaxis requiring medical attention

Arms & Interventions

Nexus Flow Generator

Experimental

Participants were randomised to Nexus Flow Generator group for one night.

Intervention: Nexus Flow Generator (Device)

VPAP Flow Generator 25

Active Comparator

Participants were randomised to VPAP Flow Generator 25 group for one night.

Intervention: VPAP Flow Generator 25 (Device)

Outcomes

Primary Outcomes

Oxygen Desaturation Index

Time Frame: One Night On Each Arm, approximately 8 hours each night

Number of oxygen desaturations per hour of sleep

Apnoea-Hypopnoea Index (AHI)

Time Frame: One Night On Each Arm, approximately 8 hours each night

The number of apneas and hypopnoeas per hour of sleep measured on Nexus Auto \& VPAP Auto 25

Secondary Outcomes

  • Comfort of Breathing(One Night On Each Arm, approximately 8 hours each night)
  • Satisfaction of Treatment(One Night On Each Arm, approximately 8 hours each night)
  • Refreshed Feel(One Night On Each Arm, approximately 8 hours each night)

Investigators

Sponsor
ResMed
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials